CX Institutional raised its stake in Quaker Houghton (NYSE:KWR - Free Report) by 183.8% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 59,592 shares of the specialty chemicals company's stock after buying an additional 38,596 shares during the quarter. CX Institutional owned approximately 0.34% of Quaker Houghton worth $6,671,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in KWR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Quaker Houghton by 3.0% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,866 shares of the specialty chemicals company's stock valued at $1,107,000 after buying an additional 230 shares during the last quarter. Millennium Management LLC grew its position in Quaker Houghton by 402.0% in the 4th quarter. Millennium Management LLC now owns 90,389 shares of the specialty chemicals company's stock valued at $12,723,000 after buying an additional 72,383 shares in the last quarter. Nuveen Asset Management LLC grew its position in Quaker Houghton by 2.6% in the 4th quarter. Nuveen Asset Management LLC now owns 54,037 shares of the specialty chemicals company's stock valued at $7,606,000 after buying an additional 1,344 shares in the last quarter. Snowden Capital Advisors LLC grew its position in Quaker Houghton by 4.9% in the 4th quarter. Snowden Capital Advisors LLC now owns 2,439 shares of the specialty chemicals company's stock valued at $343,000 after buying an additional 113 shares in the last quarter. Finally, Voloridge Investment Management LLC grew its position in Quaker Houghton by 108.9% in the 4th quarter. Voloridge Investment Management LLC now owns 96,542 shares of the specialty chemicals company's stock valued at $13,589,000 after buying an additional 50,330 shares in the last quarter. 77.46% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
KWR has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Quaker Houghton in a research report on Wednesday, August 13th. Royal Bank Of Canada set a $135.00 target price on shares of Quaker Houghton and gave the company an "outperform" rating in a research report on Monday, August 4th. Finally, Jefferies Financial Group upgraded shares of Quaker Houghton from a "hold" rating to a "buy" rating and set a $146.00 target price for the company in a research report on Monday, June 9th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $150.75.
Check Out Our Latest Research Report on Quaker Houghton
Quaker Houghton Stock Down 0.5%
KWR traded down $0.66 during midday trading on Monday, hitting $138.19. 67,073 shares of the company's stock traded hands, compared to its average volume of 167,592. The company has a market cap of $2.40 billion, a PE ratio of -321.36, a price-to-earnings-growth ratio of 1.54 and a beta of 1.44. The stock's fifty day simple moving average is $132.52 and its 200-day simple moving average is $120.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.56 and a quick ratio of 1.87. Quaker Houghton has a one year low of $95.91 and a one year high of $180.96.
Quaker Houghton (NYSE:KWR - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The specialty chemicals company reported $1.71 EPS for the quarter, missing the consensus estimate of $1.82 by ($0.11). The company had revenue of $483.40 million for the quarter, compared to analyst estimates of $463.57 million. Quaker Houghton had a negative net margin of 0.39% and a positive return on equity of 8.35%. The company's revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the business earned $2.13 EPS. As a group, equities analysts anticipate that Quaker Houghton will post 7.75 earnings per share for the current fiscal year.
Quaker Houghton Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 17th will be issued a dividend of $0.508 per share. The ex-dividend date of this dividend is Friday, October 17th. This is a boost from Quaker Houghton's previous quarterly dividend of $0.49. This represents a $2.03 dividend on an annualized basis and a dividend yield of 1.5%. Quaker Houghton's dividend payout ratio (DPR) is -472.09%.
About Quaker Houghton
(
Free Report)
Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.
Read More

Before you consider Quaker Houghton, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quaker Houghton wasn't on the list.
While Quaker Houghton currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.